Influenza viruses rapidly accumulate mutations in antibody (Ab) binding sites within the hemagglutinin (HA) and neuraminidase (NA) proteins, a process termed 'antigenic drift'. Due to antigenic drift, humans are frequently re-infected with antigenically distinct influenza strains and vaccines must be updated frequently. Influenza vaccines fail to elicit protective Ab responses in some individuals, even when vaccine strains are well matched to predominant circulating strains. Elderly individuals, who typically have extensive influenza exposure histories, respond particularly poorly to influenza vaccines. As early as the 1950's, it was noted that the human immune system preferentially mounts Ab responses to previously circulating influenza strains, as opposed to new Ab responses that exclusively target newer viral strains. This process, termed 'original antigenic sin (OAS)', has been proposed to contribute to vaccine failures in individuals with extensive influenza pre-exposure histories. We hypothesize that strain-specific Abs that recognize variable epitopes located on the top of HA are more efficient at neutralizing virus compared to OAS-induced Abs that recognize epitopes in conserved regions of HA. Previous studies of OAS have utilized influenza strains that have dramatic antigenic differences, however humans are more typically sequentially infected or vaccinated with influenza strains that have subtle antigenic changes compared to previously circulating strains. In this proposal, we will determine if OAS is induced by sequential infections with seasonal influenza strains with moderate antigenic differences. We will sequentially infect mice and ferrets with A/Puerto Rico/8/34 viruses with well defined HA antigenic mutations, and we will identify OAS-induced Abs through hemagglutination-inhibition (HAI), ELISA, ELISPOT, FACS-based Ab binding, and in vitro neutralization assays. We will complete similar vaccination experiments in pre-exposed animals with and without the MF59 adjuvant. We will then map the precise binding footprints of anti-HA mAbs derived from mice sequentially infected with distinct influenza strains. We will also map the binding footprints of a large panel of H3N2 mAbs derived from vaccinated humans with different H3N2 pre- exposure histories. Finally, we will determine in vivo neutralization efficiencies of OAS-induced murine and human mAbs using a mouse model. Collectively, these studies will determine (1) if seasonal vaccines induce OAS, (2) if OAS contributes to decreased vaccine efficacy in pre-exposed populations, and (3) if OAS Ab repertoires can be altered by MF59 adjuvants.

Public Health Relevance

The immune system preferentially mounts immune responses to old influenza strains, as opposed to new immune responses that target new viral strains. The goal of this application is to determine if previous influenza infections influence the development of new immune responses elicited by seasonal influenza vaccines, and if these immune responses can be altered by adjuvants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI108686-01A1
Application #
8718539
Study Section
Special Emphasis Panel (ZRG1-IMM-N (12))
Program Officer
Hauguel, Teresa M
Project Start
2014-08-15
Project End
2018-07-31
Budget Start
2014-08-15
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$385,850
Indirect Cost
$177,188
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Naradikian, Martin S; Myles, Arpita; Beiting, Daniel P et al. (2016) Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells. J Immunol 197:1023-8
Willis, Elinor; Parkhouse, Kaela; Krammer, Florian et al. (2016) Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States. Vaccine 34:5483-5487
Petrie, Joshua G; Parkhouse, Kaela; Ohmit, Suzanne E et al. (2016) Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains. J Infect Dis 214:1947-1951
Xue, Jia; Chambers, Benjamin S; Hensley, Scott E et al. (2016) Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations. Front Microbiol 7:326
Shaffer, Sydney M; Joshi, Rohan P; Chambers, Benjamin S et al. (2015) Multiplexed detection of viral infections using rapid in situ RNA analysis on a chip. Lab Chip 15:3170-82
Chambers, Benjamin S; Parkhouse, Kaela; Ross, Ted M et al. (2015) Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell Rep 12:1-6
Hackett, Brent A; Yasunaga, Ari; Panda, Debasis et al. (2015) RNASEK is required for internalization of diverse acid-dependent viruses. Proc Natl Acad Sci U S A 112:7797-802
Linderman, Susanne L; Chambers, Benjamin S; Zost, Seth J et al. (2014) Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proc Natl Acad Sci U S A 111:15798-803
Brockhurst, Michael A; Hensley, Scott E (2014) Editorial overview: viral evolution: exploring the frontiers of virus evolution in the lab, the field and the clinic. Curr Opin Virol 8:ix-x